Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies

Biol Psychiatry. 2015 Aug 1;78(3):167-77. doi: 10.1016/j.biopsych.2014.12.003. Epub 2014 Dec 9.

Abstract

The maladaptive expression and function of several stress-associated hormones have been implicated in pathological stress and anxiety-related disorders. Among these, recent evidence has suggested that pituitary adenylate cyclase activating polypeptide (PACAP) has critical roles in central neurocircuits mediating stress-related emotional behaviors. We describe the PACAPergic systems, the data implicating PACAP in stress biology, and how altered PACAP expression and signaling may result in psychopathologies. We include our work implicating PACAP signaling within the bed nucleus of the stria terminalis in mediating the consequences of stressor exposure and relatedly, describe more recent studies suggesting that PACAP in the central nucleus of the amygdala may impact the emotional aspects of chronic pain states. In aggregate, these results are consistent with data suggesting that PACAP dysregulation is associated with posttraumatic stress disorder in humans.

Keywords: Amygdala; Anxiety; Bed nucleus of the stria terminalis; Fear; Pain; Parabrachial nucleus.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amygdala / metabolism*
  • Animals
  • Anxiety / physiopathology
  • Behavior, Animal
  • Chickens
  • Fishes
  • Humans
  • Mice
  • Models, Animal
  • Pituitary Adenylate Cyclase-Activating Polypeptide / metabolism*
  • Rats
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I / genetics*
  • Stress Disorders, Post-Traumatic / physiopathology*
  • Stress, Psychological / physiopathology*

Substances

  • ADCYAP1R1 protein, human
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I